Literature DB >> 12952596

In vivo tracking of neural progenitor cell migration to glioblastomas.

Yi Tang1, Khalid Shah, Shanta M Messerli, Evan Snyder, Xandra Breakefield, Ralph Weissleder.   

Abstract

The ability to noninvasively track the migration, engraftment, and proliferation of neural progenitor cells (NPCs) has significant clinical and research implications. The purpose of our study was to explore the macroscopic migratory capabilities of NPCs toward brain tumors after implantation into nude mice. We stably transfected C17.2 NPCs with the firefly luciferase gene (F-luc) and implanted cells into (1) the contralateral brain parenchyma (2 x 10(6) cells), (2) the ventricles (2 x 10(6) cells), (3) the vasculature (1 x 10(5) cells), or (4) the intraperitoneal cavity (5 x 10(6) cells) of mice bearing intracranial gliomas (Gli36). Using serial bioluminescence imaging, migration of parenchymally injected cells was observed across the corpus callosum, first detected at 1 week, with maximal density at the tumor site 2-3 weeks after implantation. Similar patterns were also observed with intraventricular injections; however, tumors were populated earlier, presumably because of the shorter distance to travel. Intravenous injections resulted in more modest tumoral NPC populations, whereas virtually no cells could be identified in tumors after intraperitoneal injection. These results confirm the migratory capability of NPCs over considerable distances and their preferential accumulation in brain tumors on CNS rather than peripheral injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952596     DOI: 10.1089/104303403767740786

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  85 in total

Review 1.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

2.  Chemotactic responses of neural stem cells to SDF-1α correlate closely with their differentiation status.

Authors:  Yebing Chen; Youhua Wei; Jing Liu; Huanxiang Zhang
Journal:  J Mol Neurosci       Date:  2014-03-22       Impact factor: 3.444

Review 3.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

4.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.

Authors:  Jian Luo; Amy H Lin; Eliezer Masliah; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 5.  Molecular optical imaging: applications leading to the development of present day therapeutics.

Authors:  Khalid Shah; Ralph Weissleder
Journal:  NeuroRx       Date:  2005-04

Review 6.  Bioluminescence imaging.

Authors:  Ruxana T Sadikot; Timothy S Blackwell
Journal:  Proc Am Thorac Soc       Date:  2005

7.  Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.

Authors:  Shanthie Thamotharan; Nupur Raychaudhuri; Masatoshi Tomi; Bo-Chul Shin; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

8.  Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.

Authors:  Tugba Bagci-Onder; Wanlu Du; Jose-Luiz Figueiredo; Jordi Martinez-Quintanilla; Khalid Shah
Journal:  Brain       Date:  2015-04-23       Impact factor: 13.501

9.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

Authors:  Rachael Mooney; Yiming Weng; Revathiswari Tirughana-Sambandan; Valerie Valenzuela; Soraya Aramburo; Elizabeth Garcia; Zhongqi Li; Margarita Gutova; Alexander J Annala; Jacob M Berlin; Karen S Aboody
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

Review 10.  Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas.

Authors:  Prakash Rath; Huidong Shi; Joel A Maruniak; N Scott Litofsky; Bernard L Maria; Mark D Kirk
Journal:  Curr Stem Cell Res Ther       Date:  2009-01       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.